Skip to main content

Peer Review reports

From: Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer

Original Submission
30 May 2009 Submitted Original manuscript
18 Jul 2009 Reviewed Reviewer Report - Reiki Nishimura
22 Jul 2009 Reviewed Reviewer Report - Filippo Montemurro
26 Jul 2009 Reviewed Reviewer Report - Stefania Gori
1 Sep 2009 Author responded Author comments - Rupert Bartsch
Resubmission - Version 2
1 Sep 2009 Submitted Manuscript version 2
5 Sep 2009 Reviewed Reviewer Report - Reiki Nishimura
16 Sep 2009 Reviewed Reviewer Report - Filippo Montemurro
21 Sep 2009 Author responded Author comments - Rupert Bartsch
Resubmission - Version 3
21 Sep 2009 Submitted Manuscript version 3
12 Oct 2009 Author responded Author comments - Rupert Bartsch
Resubmission - Version 4
12 Oct 2009 Submitted Manuscript version 4
Publishing
17 Oct 2009 Editorially accepted
17 Oct 2009 Article published 10.1186/1471-2407-9-367

You can find further information about peer review here.

Back to article page